Positive Development in NICE Cabozantinib Appraisal Appeal

Positive Development in NICE Cabozantinib Appraisal Appeal

Neuroendocrine Cancer UK welcomes the outcome of the recent appeal relating to NICE’s appraisal of cabozantinib for advanced neuroendocrine tumours.  The NICE appeal panel has upheld three key appeal points while dismissing the remaining grounds of appeal. As a...

Unfortunately we are having to close our Helpline on Tuesday 6th October - however it will be open as usual on both Wednesday 7th and Thursday 8th.

X